Categories Earnings, Technology

Earnings preview: What to look for when MongoDB reports Q2 results

MongoDB Inc. (NASDAQ: MDB) is scheduled to report its second quarter 2020 earnings results on Wednesday, September 4, after regular hours. Analysts expect the company to report a loss of $0.28 per share on revenue of $91.6 million.

In the second quarter, revenues are expected to increase over 50% helped by an expansion in the customer base as well as growth in subscription revenue, aided by strong demand for its database platform. The topline results are also expected to benefit from new products like MongoDB Mobile and strong revenue in Atlas.

MongoDB quarterly customer growth trend

MongoDB faces competitive threats from Amazon’s (NYSE: AMZN) DocumentDB database and the former has been trying to diversify its portfolio by acquiring companies like mLabs and Realm. The availability of MongoDB’s cloud database in more than 60 regions is an advantage for the company.

In the first quarter of 2020, MongoDB reported better-than-expected results. Revenues rose 78% to $89.4 million while adjusted loss per share narrowed to $0.22 from $0.37 a year ago. Subscription revenues rose 82% year-over-year. The company had 14,200 customers at quarter-end.

Also see: MongoDB Q1 2020 Earnings Conference Call Transcript

For the second quarter, MongoDB has guided for revenues of $90-92 million and adjusted losses between $0.27 and $0.29 per share. For the full year, the company expects revenues of $375-381 million and adjusted loss per share of $1.11 to $1.04.

MongoDB’s shares have gained 88% thus far this year and 10% in the past three months. The majority of analysts have rated the stock as Buy and it has an average 12-month price target of $167.30.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top